Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
JYP0061 in moderate-to-severe atopic dermatitis
NCT06158490Phase 2Enrolling by invitation
- Sponsor
- Guangzhou JOYO Pharma
- Start
- Dec 2023
- Primary completion
- Feb 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of JYP0061 in atopic dermatitis (AD), sponsored by Guangzhou JOYO Pharma. Started Dec 2023; status: enrolling by invitation.
02
Drugs
JYP0061
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT06158490.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06158490.